
Analysis of possible markers of effective antitumor cellular immune response before starting therapy with immune check-point inhibitors
Author(s) -
Анна Малкова,
Р. В. Орлова,
Natalia V. Zhukova,
Anna Gubal,
Vladimir V. Sharoyko
Publication year - 2022
Publication title -
sibirskij onkologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2312-3168
pISSN - 1814-4861
DOI - 10.21294/1814-4861-2022-21-2-109-117
Subject(s) - tigit , immune system , cytotoxic t cell , cd8 , immunotherapy , immunology , biology , antigen , human leukocyte antigen , major histocompatibility complex , t cell , receptor , cancer research , genetics , in vitro